A1AT0
anisindione
| Created: | 2024-05-31 |
| Last modified: | 2025-10-22 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 31 |
| Chiral Atom Count | 0 |
| Bond Count | 33 |
| Aromatic Bond Count | 12 |
Chemical Component Summary | |
|---|---|
| Name | anisindione |
| Synonyms | 2-(4-methoxyphenyl)-1H-indene-1,3(2H)-dione |
| Systematic Name (OpenEye OEToolkits) | 2-(4-methoxyphenyl)indene-1,3-dione |
| Formula | C16 H12 O3 |
| Molecular Weight | 252.265 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 14.52 | COc1ccc(cc1)C1C(=O)c2ccccc2C1=O |
| SMILES | CACTVS | 3.385 | COc1ccc(cc1)C2C(=O)c3ccccc3C2=O |
| SMILES | OpenEye OEToolkits | 3.1.0.0 | COc1ccc(cc1)C2C(=O)c3ccccc3C2=O |
| Canonical SMILES | CACTVS | 3.385 | COc1ccc(cc1)C2C(=O)c3ccccc3C2=O |
| Canonical SMILES | OpenEye OEToolkits | 3.1.0.0 | COc1ccc(cc1)C2C(=O)c3ccccc3C2=O |
| InChI | InChI | 1.06 | InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3 |
| InChIKey | InChI | 1.06 | XRCFXMGQEVUZFC-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB01125 |
|---|---|
| Name | Anisindione |
| Groups | approved |
| Description | Anisindione is a synthetic anticoagulant and an indanedione derivative. Its anticoagulant action is mediated through the inhibition of the vitamin K-mediated gamma-carboxylation of precursor proteins that are critical in forming the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver. |
| Synonyms |
|
| Indication | For the prophylaxis and treatment of venous thrombosis and its extension, the treatment of atrial fibrillation with embolization, the prophylaxis and treatment of pulmonary embolism, and as an adjunct in the treatment of coronary occlusion. |
| Categories |
|
| CAS number | 117-37-3 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Vitamin K-dependent gamma-carboxylase | MAVSAGSARTSPSSDKVQKDKAELISGPRQDSRIGKLLGFEWTDLSSWRR... | unknown | inhibitor |
| Prothrombin | MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEE... | unknown | modulator |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL712 |
| PubChem | 2197 |
| ChEMBL | CHEMBL712 |
| ChEBI | CHEBI:133809 |














